FDA NDC Directory · JSON-LD · Markdown

Gadoquatrane

NDC 12866-3230 · DRUG FOR FURTHER PROCESSING · INJECTION

Labeler / ManufacturerBayer AG
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION
Active ingredientsGADOQUATRANE (257.9 mg/mL)
Marketing started20260612
Package count3

External sources

Source: openFDA. Public-domain (CC0).